Recurrence and prognostic model for identifying patients at risk for esophageal cancer after surgery

被引:4
作者
Chen, Dongni [1 ]
Wang, Weidong [1 ]
Chen, Youfang [1 ]
Hu, Jia [1 ]
Yang, Men [2 ]
Mo, Junxian [3 ]
Wen, Zhesheng [1 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Thorac Oncol,State Key Lab Oncol South China, 651 Dongfengdong, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Cardiothorac Surg, Shenzhen 518000, Guangdong, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 7, Dept Cardiothorac Surg, Wuzhou 543000, Guangxi, Peoples R China
关键词
esophageal cancer; surgery; recurrence; prognosis; model; SQUAMOUS-CELL CARCINOMA; NEGATIVE LYMPH-NODES; ESOPHAGOGASTRIC JUNCTION; THORACIC ESOPHAGUS; GASTRIC-CANCER; IVOR-LEWIS; NUMBER; SURVIVAL; EDITION; PATTERN;
D O I
10.2147/CMAR.S186194
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of this study was to construct a risk model to assess overall survival (OS) and disease-free survival (DFS) in patients with esophageal cancer (EC) after surgery. Patients and methods: A total of 872 consecutive EC patients who had undergone surgery between February 2009 and October 2012 were retrospectively analyzed. The cutoff for risk value (RV) was inferred by receiver operating characteristic curves and the Youden index. A log-rank test was used to compare the survival curves, and a Cox regression analysis was performed to clarify the significant prognostic factors. Results: The area under the curve was 0.688 for OS and 0.645 for DFS. The survival rates were 69.4% (259/373) and 39.1% (195/499), and the rates of recurrence were 19.2% (70/364) and 27.6% (132/479), respectively, for RV<0.218 and RV >= 0.218 (chi(2) =78.83, P<0.001; chi(2) =9.07, P=0.003; respectively). A multivariate Cox regression analysis identified cases suffering from higher overall mortalities with RV >= 0.218 compared to RV<0.218 (HR=1.45; 95% CI, 1.21-2.02; P=0.015); similar results were also found for DES (HR=1.38; 95% CI, 1.03 1.86; P=0.033). Kaplan-Meier survival curves showed that cases with RV<0.218 had better OS and DFS than cases with RV >= 0.218 (log rank = 75.80, P<0.001; log rank = 24.78, P<0.001). Conclusion: This model could be applied to an integrated assessment of recurrence and prognostic risk alter the surgical treatment of EC.
引用
收藏
页码:6109 / 6120
页数:12
相关论文
共 35 条
[1]   The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery [J].
Agha, Riaz Ahmed ;
Borrelli, Mimi R. ;
Vella-Baldacchino, Martinique ;
Thavayogan, Rachel ;
Orgill, Dennis P. .
INTERNATIONAL JOURNAL OF SURGERY, 2017, 46 :198-202
[2]   Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer [J].
Ajani, J. A. ;
Correa, A. M. ;
Hofstetter, W. L. ;
Rice, D. C. ;
Blum, M. A. ;
Suzuki, A. ;
Taketa, T. ;
Welsh, J. ;
Lin, S. H. ;
Lee, J. H. ;
Bhutani, M. S. ;
Ross, W. A. ;
Maru, D. M. ;
Macapinlac, H. A. ;
Erasmus, J. ;
Komaki, R. ;
Mehran, R. J. ;
Vaporciyan, A. A. ;
Swisher, S. G. .
ANNALS OF ONCOLOGY, 2012, 23 (10) :2638-2642
[3]   Total number of resected lymph nodes predicts survival in esophageal cancer [J].
Altorki, Nasser K. ;
Zhou, Xi Kathy ;
Stiles, Brendon ;
Port, Jeffrey L. ;
Paul, Subroto ;
Lee, Paul C. ;
Mazumdar, Madhu .
ANNALS OF SURGERY, 2008, 248 (02) :221-226
[4]  
[Anonymous], ANN SURG
[5]   Is it time for a new TNM classification in esophageal carcinoma? [J].
Bogoevski, Dean ;
Onken, Florian ;
Koenig, Alexandra ;
Kaifi, Jussuf T. ;
Schurr, Paulus ;
Sauter, Guido ;
Izbicki, Jakob R. ;
Yekebas, Emre F. .
ANNALS OF SURGERY, 2008, 247 (04) :633-641
[6]   Staging of esophageal carcinoma:: Length of tumor and number of involved regional lymph nodes.: Are these independent prognostic factors? [J].
Bollschweiler, Elfriede ;
Baldus, Stephan E. ;
Schroeder, Wolfgang ;
Schneider, Paul M. ;
Hoelscher, Arnulf H. .
JOURNAL OF SURGICAL ONCOLOGY, 2006, 94 (05) :355-363
[7]   Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial [J].
Burmeister, BH ;
Smithers, BM ;
Gebski, V ;
Fitzgerald, L ;
Simes, RJ ;
Devitt, P ;
Ackland, S ;
Gotley, DC ;
Joseph, D ;
Millar, J ;
North, J ;
Walpole, ET ;
Denham, JW .
LANCET ONCOLOGY, 2005, 6 (09) :659-668
[8]   Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified ivor-lewis esophagectomy [J].
Chen, Gang ;
Wang, Zhou ;
Liu, Xiang-yan ;
Liu, Fan-ying .
WORLD JOURNAL OF SURGERY, 2007, 31 (05) :1107-1114
[9]   The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma [J].
Chen, Junqiang ;
Liu, Suoyan ;
Pan, Jianji ;
Zheng, Xiongwei ;
Zhu, Kunshou ;
Zhu, Ji ;
Xiao, Jinrong ;
Ying, Mingang .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 36 (03) :480-486
[10]   Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries [J].
Domper Arnal, Maria Jose ;
Ferrandez Arenas, Angel ;
Lanas Arbeloa, Angel .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (26) :7933-7943